Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-012101
Filing Date
2024-03-20
Accepted
2024-03-20 11:13:25
Documents
11
Period of Report
2024-03-20

Document Format Files

Seq Description Document Type Size
1 6-K a240320_6kxmorxvotingright.htm 6-K 10949
2 EX-99.1 exhibit_991.htm EX-99.1 5299
3 EX-99.2 exhibit_992.htm EX-99.2 5071
4 GRAPHIC exhibit_991001.jpg GRAPHIC 117124
5 GRAPHIC exhibit_991002.jpg GRAPHIC 128733
6 GRAPHIC exhibit_991003.jpg GRAPHIC 124852
7 GRAPHIC exhibit_991004.jpg GRAPHIC 73065
8 GRAPHIC exhibit_992001.jpg GRAPHIC 117981
9 GRAPHIC exhibit_992002.jpg GRAPHIC 126004
10 GRAPHIC exhibit_992003.jpg GRAPHIC 127829
11 GRAPHIC exhibit_992004.jpg GRAPHIC 52898
  Complete submission text file 0001628280-24-012101.txt   1219203
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 24766853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)